REPORT ID 3377

United States Ocular Drug Delivery Market Report 2017

Publish Date
13-Dec-17
Pages
99
Format
Electronic (PDF)

In this report, the United States Ocular Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Ocular Drug Delivery in these regions, from 2012 to 2022 (forecast).

United States Ocular Drug Delivery market competition by top manufacturers/players, with Ocular Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    OCULAR THERAPEUTIX, INC
    Alimera Sciences
    Allergan, Plc
    EyeGate Pharma
    Valeant Pharmaceuticals International, Inc
    Envisia Therapeutics
    Clearside Biomedical
    Graybug Vision Inc
    Taiwan Liposome Company
    Santen Pharmaceutical Co., Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    By Technology
        Ocular Insert
        Iontophoresis
        Intraocular Implants
        In Situ Gel & Punctal Plugs
        Others
    By Form
        Solution
        Suspension
        Emulsion
        Liposomes & Nanoparticles
        Ointment
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Ambulatory Surgical Centers
    Ophthalmic Clinics
    Homecare Settings

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Ocular Drug Delivery Market Report 2017
1 Ocular Drug Delivery Overview
    1.1 Product Overview and Scope of Ocular Drug Delivery
    1.2 Classification of Ocular Drug Delivery by Product Category
        1.2.1 United States Ocular Drug Delivery Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Ocular Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Ocular Insert
        1.2.4 Iontophoresis
        1.2.5 Intraocular Implants
        1.2.6 In Situ Gel & Punctal Plugs
        1.2.7 Others
    1.3 United States Ocular Drug Delivery Market by Application/End Users
        1.3.1 United States Ocular Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Ophthalmic Clinics
        1.3.5 Homecare Settings
    1.4 United States Ocular Drug Delivery Market by Region
        1.4.1 United States Ocular Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Ocular Drug Delivery Status and Prospect (2012-2022)
        1.4.3 Southwest Ocular Drug Delivery Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Ocular Drug Delivery Status and Prospect (2012-2022)
        1.4.5 New England Ocular Drug Delivery Status and Prospect (2012-2022)
        1.4.6 The South Ocular Drug Delivery Status and Prospect (2012-2022)
        1.4.7 The Midwest Ocular Drug Delivery Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Ocular Drug Delivery (2012-2022)
        1.5.1 United States Ocular Drug Delivery Sales and Growth Rate (2012-2022)
        1.5.2 United States Ocular Drug Delivery Revenue and Growth Rate (2012-2022)

2 United States Ocular Drug Delivery Market Competition by Players/Suppliers
    2.1 United States Ocular Drug Delivery Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Ocular Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Ocular Drug Delivery Average Price by Players/Suppliers (2012-2017)
    2.4 United States Ocular Drug Delivery Market Competitive Situation and Trends
        2.4.1 United States Ocular Drug Delivery Market Concentration Rate
        2.4.2 United States Ocular Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Ocular Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type

3 United States Ocular Drug Delivery Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Ocular Drug Delivery Sales and Market Share by Region (2012-2017)
    3.2 United States Ocular Drug Delivery Revenue and Market Share by Region (2012-2017)
    3.3 United States Ocular Drug Delivery Price by Region (2012-2017)

4 United States Ocular Drug Delivery Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Ocular Drug Delivery Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Ocular Drug Delivery Revenue and Market Share by Type (2012-2017)
    4.3 United States Ocular Drug Delivery Price by Type (2012-2017)
    4.4 United States Ocular Drug Delivery Sales Growth Rate by Type (2012-2017)

5 United States Ocular Drug Delivery Sales (Volume) by Application (2012-2017)
    5.1 United States Ocular Drug Delivery Sales and Market Share by Application (2012-2017)
    5.2 United States Ocular Drug Delivery Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Ocular Drug Delivery Players/Suppliers Profiles and Sales Data
    6.1 OCULAR THERAPEUTIX, INC
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Ocular Drug Delivery Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Alimera Sciences
        6.2.2 Ocular Drug Delivery Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Allergan, Plc
        6.3.2 Ocular Drug Delivery Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 EyeGate Pharma
        6.4.2 Ocular Drug Delivery Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Valeant Pharmaceuticals International, Inc
        6.5.2 Ocular Drug Delivery Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Envisia Therapeutics
        6.6.2 Ocular Drug Delivery Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Clearside Biomedical
        6.7.2 Ocular Drug Delivery Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Graybug Vision Inc
        6.8.2 Ocular Drug Delivery Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Taiwan Liposome Company
        6.9.2 Ocular Drug Delivery Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Santen Pharmaceutical Co., Ltd
        6.10.2 Ocular Drug Delivery Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Ocular Drug Delivery Manufacturing Cost Analysis
    7.1 Ocular Drug Delivery Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Ocular Drug Delivery

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Ocular Drug Delivery Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Ocular Drug Delivery Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Ocular Drug Delivery Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Ocular Drug Delivery Sales Volume Forecast by Type (2017-2022)
    11.3 United States Ocular Drug Delivery Sales Volume Forecast by Application (2017-2022)
    11.4 United States Ocular Drug Delivery Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer